1. Home
  2. PTGX vs CBT Comparison

PTGX vs CBT Comparison

Compare PTGX & CBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • CBT
  • Stock Information
  • Founded
  • PTGX 2006
  • CBT 2019
  • Country
  • PTGX United States
  • CBT United States
  • Employees
  • PTGX N/A
  • CBT N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • CBT Major Chemicals
  • Sector
  • PTGX Health Care
  • CBT Industrials
  • Exchange
  • PTGX Nasdaq
  • CBT Nasdaq
  • Market Cap
  • PTGX 4.0B
  • CBT 4.0B
  • IPO Year
  • PTGX 2016
  • CBT N/A
  • Fundamental
  • Price
  • PTGX $78.62
  • CBT $67.48
  • Analyst Decision
  • PTGX Strong Buy
  • CBT Hold
  • Analyst Count
  • PTGX 9
  • CBT 3
  • Target Price
  • PTGX $78.11
  • CBT $85.00
  • AVG Volume (30 Days)
  • PTGX 1.6M
  • CBT 424.6K
  • Earning Date
  • PTGX 10-31-2025
  • CBT 11-03-2025
  • Dividend Yield
  • PTGX N/A
  • CBT 2.67%
  • EPS Growth
  • PTGX N/A
  • CBT N/A
  • EPS
  • PTGX 0.80
  • CBT 7.65
  • Revenue
  • PTGX $209,180,000.00
  • CBT $3,815,000,000.00
  • Revenue This Year
  • PTGX N/A
  • CBT N/A
  • Revenue Next Year
  • PTGX $142.86
  • CBT $3.41
  • P/E Ratio
  • PTGX $97.73
  • CBT $8.82
  • Revenue Growth
  • PTGX N/A
  • CBT N/A
  • 52 Week Low
  • PTGX $33.31
  • CBT $65.59
  • 52 Week High
  • PTGX $93.25
  • CBT $117.46
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 61.88
  • CBT 27.18
  • Support Level
  • PTGX $73.08
  • CBT $70.90
  • Resistance Level
  • PTGX $79.00
  • CBT $71.86
  • Average True Range (ATR)
  • PTGX 2.39
  • CBT 1.47
  • MACD
  • PTGX -0.24
  • CBT -0.03
  • Stochastic Oscillator
  • PTGX 93.42
  • CBT 27.88

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

Share on Social Networks: